Bone Death: What You Should Know About Common Bone Loss Drugs

If you want to keep dancing as you grow old take heed of a recent report from the Journal of Rheumatology. A few weeks ago it published a study that showed a connection between bone death (bone necrosis) and the class of commonly prescribed drugs known as Bisphosphonates (Fosamax, Actonel, Boniva, Skelid, and Didronel). 196 cases of bone death were discovered among 87,837 otherwise healthy men and women using these medications.

This report is the first of its kind to clearly link these drugs to an increase in serious, irreversible bone death. We’re talking here about normal individuals, who took these drugs orally for an average of only two years, not cancer patients or patients taking massive amounts of these medications intravenously (as previously reported). These medications have been in use since 1995, and we are just now beginning to see their long-term adverse effects. What is worse, these drugs stay in the bones for decades and their effects cannot be reversed.

Although such drugs create denser bone, unfortunately they also interfere with normal bone health by preventing new bone from forming. Your bones may look better (denser) on bone density testing, but this does not guarantee strong bones. Why? Because these medications don’t stimulate new bone growth- in fact, they prevent new bone growth. Only new bone is strong and resilient. Old mineralized bone is brittle. So these drugs do only half the job (processing bone breakdown) and interfere with the other very necessary half (building new bone). What you need are hormones, vitamins, minerals, protein, good digestion, and a steady exercise routine to keep your bones strong and to rebuild weak bones.

I recently updated the topic section of my website to include new topics. In the Bone Health Section I discuss how healthy bones grow and how to maintain and improve bone health naturally. Check it out to keep dancing as you age.

Leave a comment

Your email address will not be published. Required fields are marked *